Retatrutide + Cagrilintide Blend (10mg Co-Lyophilized Dual Agonist)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
The Retatrutide + Cagrilintide Blend (RC10) is a co-lyophilized metabolic research preparation combining 5 mg of Retatrutide (GIP/GLP-1/Glucagon tri-agonist) with 5 mg of Cagrilintide (dual amylin and calcitonin receptor agonist) in a precise 1:1 molar-adjusted mass ratio. This multi-target incretin-amylin formulation permits laboratory investigation into the synergistic potentiation of peripheral energy expenditure, hepatic lipid clearance, and neuroendocrine satiety signaling.
Compound & Molecular Specifications
Certificate of Analysis StandardsAll-in-One Pre-Mixed Peptide Formulation
This product is a Blend (1 physical vial) where active peptide compounds are co-lyophilized into a single cake for simplified reconstitution. If your research requires staggered administration windows (e.g. Fasted AM vs Pre-Bed PM) or custom stoichiometric titrations, you can stack separate vials in our Stacking Studio.
